159 related articles for article (PubMed ID: 24970355)
21. Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions.
Haller F; Löbke C; Ruschhaupt M; Schulten HJ; Schwager S; Gunawan B; Armbrust T; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
J Pathol; 2008 Oct; 216(2):225-35. PubMed ID: 18729075
[TBL] [Abstract][Full Text] [Related]
22. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.
Quattrone A; Dewaele B; Wozniak A; Bauters M; Vanspauwen V; Floris G; Schöffski P; Chibon F; Coindre JM; Sciot R; Debiec-Rychter M
J Pathol; 2012 Dec; 228(4):565-74. PubMed ID: 22786615
[TBL] [Abstract][Full Text] [Related]
23. An inhibitor of the acetyltransferases CBP/p300 exerts antineoplastic effects on gastrointestinal stromal tumor cells.
Gu ML; Wang YM; Zhou XX; Yao HP; Zheng S; Xiang Z; Ji F
Oncol Rep; 2016 Nov; 36(5):2763-2770. PubMed ID: 27633918
[TBL] [Abstract][Full Text] [Related]
24. Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.
Li FP; Fletcher JA; Heinrich MC; Garber JE; Sallan SE; Curiel-Lewandrowski C; Duensing A; van de Rijn M; Schnipper LE; Demetri GD
J Clin Oncol; 2005 Apr; 23(12):2735-43. PubMed ID: 15837988
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Gene Expression Profile Between Tumor Tissue and Adjacent Non-tumor Tissue in Patients with Gastric Gastrointestinal Stromal Tumor (GIST).
Kou Y; Zhao Y; Bao C; Wang Q
Cell Biochem Biophys; 2015 Jun; 72(2):571-8. PubMed ID: 25586720
[TBL] [Abstract][Full Text] [Related]
26. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
[TBL] [Abstract][Full Text] [Related]
27. Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling.
Zhang S; Zhang L; Zhang D; Guo Y; Gao Y; Jiang Z; Li S; Liu A; Cao X; Tian J; Zhao S; Yu Y; Yang W; Bai R; Huang L; Yan H; Zhao H; Sun J
Mol Carcinog; 2024 Jul; 63(7):1334-1348. PubMed ID: 38629424
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
30. High APRIL expression correlates with unfavourable survival of gastrointestinal stromal tumour.
Xian H; Zhang H; Zhu H; Wang X; Tang X; Mao Y; Zhu J
Pathology; 2014 Dec; 46(7):617-22. PubMed ID: 25393252
[TBL] [Abstract][Full Text] [Related]
31. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
Sabah M; Cummins R; Leader M; Kay E
Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
[TBL] [Abstract][Full Text] [Related]
32. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
33. Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors.
Paner GP; Silberman S; Hartman G; Micetich KC; Aranha GV; Alkan S
Anticancer Res; 2003; 23(3B):2253-60. PubMed ID: 12894500
[TBL] [Abstract][Full Text] [Related]
34. Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor.
Kubota D; Yoshida A; Tsuda H; Suehara Y; Okubo T; Saito T; Orita H; Sato K; Taguchi T; Yao T; Kaneko K; Katai H; Kawai A; Kondo T
PLoS One; 2013; 8(8):e73896. PubMed ID: 23977394
[TBL] [Abstract][Full Text] [Related]
35. The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor.
Zhang JQ; Bosbach B; Loo JK; Vitiello GA; Zeng S; Seifert AM; Medina BD; Param NJ; Maltbaek JH; Rossi F; Antonescu CR; Besmer P; DeMatteo RP
Oncogene; 2020 Dec; 39(49):7153-7165. PubMed ID: 33024275
[TBL] [Abstract][Full Text] [Related]
36. Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells.
Berglund E; Ubhayasekera SJ; Karlsson F; Akcakaya P; Aluthgedara W; Ahlen J; Fröbom R; Nilsson IL; Lui WO; Larsson C; Zedenius J; Bergquist J; Bränström R
Anticancer Drugs; 2014 Apr; 25(4):415-22. PubMed ID: 24361761
[TBL] [Abstract][Full Text] [Related]
37. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile.
Allander SV; Nupponen NN; Ringnér M; Hostetter G; Maher GW; Goldberger N; Chen Y; Carpten J; Elkahloun AG; Meltzer PS
Cancer Res; 2001 Dec; 61(24):8624-8. PubMed ID: 11751374
[TBL] [Abstract][Full Text] [Related]
39. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.
Kang DY; Park CK; Choi JS; Jin SY; Kim HJ; Joo M; Kang MS; Moon WS; Yun KJ; Yu ES; Kang H; Kim KM
Am J Surg Pathol; 2007 Feb; 31(2):224-32. PubMed ID: 17255767
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors.
Daum O; Grossmann P; Vanecek T; Sima R; Mukensnabl P; Michal M
Ann Diagn Pathol; 2007 Feb; 11(1):27-33. PubMed ID: 17240304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
